Daesang Corp Preference Shares (001685) — Free Cash Flow Generation Index

Latest as of December 2024: 0.28x

Daesang Corp Preference Shares (001685) has a Free Cash Flow Generation Index of 0.28x as of December 2024. Free cash flow of ₩9.93 Billion represents 0% of operating cash flow (₩35.63 Billion). See Daesang Corp Preference Shares current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.28x
Free Cash Flow / Operating CF

Free Cash Flow

₩9.93 Billion
KRW

Operating Cash Flow

₩35.63 Billion
KRW

Capital Expenditures

₩25.70 Billion
KRW

Daesang Corp Preference Shares Free Cash Flow Generation Index (2014–2024)

Historical FCF Generation Index trend for Daesang Corp Preference Shares across 10 annual periods. Explore debt repayment capacity of Daesang Corp Preference Shares to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Daesang Corp Preference Shares (2014–2024)

Year-by-year Free Cash Flow Generation Index for Daesang Corp Preference Shares. For the full company profile including market capitalisation, see 001685 market cap overview.

Year FCG Index Free Cash Flow (KRW) Operating CF Capital Expenditures YoY Change
2024 0.19x ₩36.46 Billion ₩187.74 Billion ₩151.29 Billion ▼ -61.0%
2023 0.50x ₩186.76 Billion ₩374.84 Billion ₩188.08 Billion ▲ +127.5%
2021 -1.81x ₩-106.27 Billion ₩58.66 Billion ₩160.12 Billion ▼ -2317.2%
2020 0.08x ₩9.89 Billion ₩121.07 Billion ₩103.82 Billion ▼ -74.3%
2019 0.32x ₩53.19 Billion ₩167.27 Billion ₩109.76 Billion ▲ +240.9%
2018 -0.23x ₩-27.43 Billion ₩121.56 Billion ₩146.32 Billion ▼ -258.7%
2017 0.14x ₩23.63 Billion ₩166.19 Billion ₩139.14 Billion ▼ -95.6%
2016 3.20x ₩175.25 Billion ₩54.77 Billion ₩120.49 Billion ▲ +6.6%
2015 3.00x ₩277.30 Billion ₩92.40 Billion ₩184.91 Billion ▲ +77.8%
2014 1.69x ₩274.66 Billion ₩162.75 Billion ₩111.91 Billion
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).